A Study of MRG002 in Patients with HER2-Positive Advanced Solid Tumors and Locally Advanced or Metastatic Gastric/Gastroesophageal Junction (GEJ) Cancer

Clinical trial NCT04492488 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04492488
Sponsor: Shanghai Miracogen Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumors Advanced or Metastatic Gastric Cancer Advanced or Metastatic Gastroesophageal Junction Cancer

Start date: 2021-05-24
Primary completion: 2022-10-18
Enrollment: 129

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.